These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 31503071)
21. Olvanil: a non-pungent TRPV1 activator has anti-emetic properties in the ferret. Chu KM; Ngan MP; Wai MK; Yeung CK; Andrews PL; Percie du Sert N; Rudd JA Neuropharmacology; 2010 Feb; 58(2):383-91. PubMed ID: 19825380 [TBL] [Abstract][Full Text] [Related]
23. Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A. Darmani NA Neuropsychopharmacology; 2001 Feb; 24(2):198-203. PubMed ID: 11120402 [TBL] [Abstract][Full Text] [Related]
24. The emetic and anti-emetic effects of the capsaicin analogue resiniferatoxin in Suncus murinus, the house musk shrew. Andrews PL; Okada F; Woods AJ; Hagiwara H; Kakaimoto S; Toyoda M; Matsuki N Br J Pharmacol; 2000 Jul; 130(6):1247-54. PubMed ID: 10903962 [TBL] [Abstract][Full Text] [Related]
25. Serotonin 5-HT3 receptor-mediated vomiting occurs via the activation of Ca2+/CaMKII-dependent ERK1/2 signaling in the least shrew (Cryptotis parva). Zhong W; Hutchinson TE; Chebolu S; Darmani NA PLoS One; 2014; 9(8):e104718. PubMed ID: 25121483 [TBL] [Abstract][Full Text] [Related]
26. Thapsigargin-induced activation of Ca(2+)-CaMKII-ERK in brainstem contributes to substance P release and induction of emesis in the least shrew. Zhong W; Chebolu S; Darmani NA Neuropharmacology; 2016 Apr; 103():195-210. PubMed ID: 26631534 [TBL] [Abstract][Full Text] [Related]
27. Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis. Darmani NA J Neural Transm (Vienna); 1998; 105(10-12):1143-54. PubMed ID: 9928884 [TBL] [Abstract][Full Text] [Related]
28. Cyclophosphamide causes activation of protein kinase A (PKA) in the brainstem of vomiting least shrews (Cryptotis parva). Alkam T; Chebolu S; Darmani NA Eur J Pharmacol; 2014 Jan; 722():156-64. PubMed ID: 24513510 [TBL] [Abstract][Full Text] [Related]
29. Differential and additive suppressive effects of 5-HT3 (palonosetron)- and NK1 (netupitant)-receptor antagonists on cisplatin-induced vomiting and ERK1/2, PKA and PKC activation. Darmani NA; Zhong W; Chebolu S; Mercadante F Pharmacol Biochem Behav; 2015 Apr; 131():104-11. PubMed ID: 25687374 [TBL] [Abstract][Full Text] [Related]
30. The anti-asthmatic drug pranlukast suppresses the delayed-phase vomiting and reverses intracellular indices of emesis evoked by cisplatin in the least shrew (Cryptotis parva). Darmani NA; Chebolu S; Zhong W; Kim WD; Narlesky M; Adams J; Dong F Eur J Pharmacol; 2017 Aug; 809():20-31. PubMed ID: 28501575 [TBL] [Abstract][Full Text] [Related]
31. The HCN Channel Blocker ZD7288 Induces Emesis in the Least Shrew ( Zhong W; Darmani NA Front Pharmacol; 2021; 12():647021. PubMed ID: 33995059 [TBL] [Abstract][Full Text] [Related]
32. A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew). Kwiatkowska M; Parker LA; Burton P; Mechoulam R Psychopharmacology (Berl); 2004 Jul; 174(2):254-9. PubMed ID: 14740147 [TBL] [Abstract][Full Text] [Related]
33. Delta 9-tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew. Ray AP; Griggs L; Darmani NA Behav Brain Res; 2009 Jan; 196(1):30-6. PubMed ID: 18721829 [TBL] [Abstract][Full Text] [Related]
34. The antiemetic interaction of Delta9-tetrahydrocannabinol when combined with tropisetron or dexamethasone in the least shrew. Wang Y; Ray AP; McClanahan BA; Darmani NA Pharmacol Biochem Behav; 2009 Jan; 91(3):367-73. PubMed ID: 18727934 [TBL] [Abstract][Full Text] [Related]
35. Central and peripheral emetic loci contribute to vomiting evoked by the Akt inhibitor MK-2206 in the least shrew model of emesis. Zhong W; Chebolu S; Darmani NA Eur J Pharmacol; 2021 Jun; 900():174065. PubMed ID: 33775646 [TBL] [Abstract][Full Text] [Related]
36. RNA sequencing least shrew ( Irizarry KJL; Zhong W; Sun Y; Kronmiller BA; Darmani NA Front Genet; 2023; 14():975087. PubMed ID: 36865388 [TBL] [Abstract][Full Text] [Related]
37. The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids. Darmani NA J Pharmacol Exp Ther; 2002 Jan; 300(1):34-42. PubMed ID: 11752094 [TBL] [Abstract][Full Text] [Related]
38. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108 [TBL] [Abstract][Full Text] [Related]
39. Intracellular emetic signaling cascades by which the selective neurokinin type 1 receptor (NK Zhong W; Chebolu S; Darmani NA Neurochem Int; 2019 Jan; 122():106-119. PubMed ID: 30453005 [TBL] [Abstract][Full Text] [Related]
40. The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2. Darmani NA Eur J Pharmacol; 2001 Oct; 430(1):49-58. PubMed ID: 11698062 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]